Maximum quantity allowed is 999
CAS RN: 27314-97-2 | Product Number: T3823
Tirapazamine
Purity: >98.0%(HPLC)
- SR 259075
- 3-Aminobenzo[e][1,2,4]triazine 1,4-Dioxide
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 50MG |
₹5,200.00
|
1 | 28 |
|
| 250MG |
₹25,000.00
|
Contact Us | 14 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | T3823 |
Purity / Analysis Method
|
>98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__7H__6N__4O__2 = 178.15 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
Packaging and Container
|
50MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 27314-97-2 |
| Reaxys Registry Number | 179322 |
| PubChem Substance ID | 468592963 |
| Merck Index (14) | 9461 |
| MDL Number | MFCD00132954 |
| Appearance | Orange to Red powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Melting Point | 230 °C(dec.) |
| Maximum Absorption Wavelength | 457 nm (H__2O) |
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| Precautionary Statements | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. |
| RTECS# | DM0671500 |
References
- 1) SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells
- 2) SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours (a review)
- 3) The hypoxic cell: a target for selective cancer therapy-eighteenth Bruce F. Cain memorial award lecture
- 4) Selective Potentiation of the Hypoxic Cytotoxicity of Tirapazamine by Its 1-N-Oxide Metabolite SR 4317
- 5) Q6, a novel hypoxia-targeted drug, regulates hypoxia-inducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.
